Speeding Drug Discovery Into Development
CRO specializing in small molecule chromatography and purification
Since our founding in 2007, Averica Discovery has built a reputation for excellence, speed, and solving tough problems.
Chiral preparative chromatography can support purification of a variety of difficult to purify substances (natural products, impurities and degradants, external contaminants).
Increasing attention on impurities in product development (degradants, solvents, external contaminants, genotoxic impurities, organic or inorganic) places an unprecedented burden on sponsors.
Developing analytical methods that are robust, transferable, reproducible, and designed to generate quality results is the ultimate goal. Averica’s method development services ensure that your team makes the best decisions and hits drug development milestones.
EPSA is a supercritical fluid chromatography (SFC) technique for peptides that enables improved permeability design and can be used as a permeability surrogate. This method is used to assess polarity by retention time using controlled SFC conditions in a standardized method.
Averica helps late state lead development teams understand the physiochemical properties of their lead compound. Obtain detailed quantitative results from physical properties assessment using a range of chromatography technologies.
Unlock The Potential Of Your Developing Drug
Averica has built a proven track record in providing clients with high quality materials, and the information they need to transition projects from discovery into development. This ability starts by understanding the specific needs of each project. Please give us a brief description of the needs for your project in the contact form below.